Prostamax
Lab-Tested ≥98% Purity · Certificate of Analysis Included · Global Shipping
Prostamax (Lys-Glu-Asp-Pro) — Prostate Bioregulator Peptide for Urological Research
Prostamax is a synthetic tetrapeptide bioregulator developed at the St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson's research group. As a prostate-specific bioregulator, Prostamax has been characterized for its regulatory effects on prostatic epithelial cell gene expression, androgen receptor signaling modulation, and maintenance of normal glandular architecture. Published research in Advances in Gerontology has documented its capacity to normalize prostatic function parameters and preserve tissue homeostasis in aged animal models exhibiting benign prostatic changes.
Mechanism of Action
Prostamax operates through the established Khavinson bioregulator mechanism of direct DNA interaction at tissue-specific gene loci. The tetrapeptide modulates chromatin accessibility at promoter regions controlling prostatic epithelial differentiation markers, androgen receptor co-regulator expression, and growth factor signaling cascades (EGF, FGF, TGF-β). Research has demonstrated normalization of the proliferation/apoptosis balance in prostatic epithelium, with selective downregulation of proliferative signals while maintaining secretory function gene expression.
Key Research Areas
- Prostatic Epithelial Homeostasis: In-vitro studies on prostatic epithelial cell cultures have demonstrated that Prostamax normalizes cell cycle progression, reducing aberrant proliferative activity while preserving differentiated secretory function markers (PSA, prostatic acid phosphatase).
- Androgen Receptor Modulation: Research has shown that Prostamax influences androgen receptor co-regulator expression profiles, modulating transcriptional output without directly competing for receptor binding—a unique regulatory mechanism distinct from anti-androgen pharmacology.
- Glandular Architecture: Histological studies in aged rodent prostate tissue have documented preserved acinar structure, maintained basal cell layer integrity, and reduced stromal/epithelial ratio following chronic Prostamax treatment.
- Inflammatory Modulation: Research has observed reduced prostatic inflammation markers (COX-2, NF-κB nuclear translocation) and normalized cytokine profiles in prostate tissue from aged Prostamax-treated animals compared to untreated controls.
Technical Specifications
- Dosage per vial: 10mg lyophilized powder
- Purity: ≥98% (HPLC verified)
- Storage: -20°C, protected from light
Why Researchers Choose Peptides BioLab
Every batch of Prostamax supplied by Peptides BioLab undergoes rigorous HPLC and mass spectrometry analysis, ensuring ≥98% purity verified by an independent Certificate of Analysis (CoA). Our product is supplied as a lyophilized powder for maximum stability, shipped worldwide in temperature-controlled packaging.
Related Research Peptides
Researchers studying prostate bioregulation and male health may also find these compounds relevant: Testagen, Kisspeptin, and Thymalin. For a complete overview, browse our Sexual Health Research collection.
For research purposes only — Not for human consumption. All products are intended solely for in-vitro research and laboratory use.
Every Peptides BioLab product includes a Certificate of Analysis (CoA) with HPLC and MS data confirming ≥98% purity. The CoA is available in the product tabs as the 2nd image, or contact our team to request a copy.
Shipping: We ship worldwide from our state-of-the-art facilities. Orders are processed within 1–2 business days. Express and standard shipping options available at checkout.
Storage: Store lyophilized peptides at -20°C for long-term storage. Once reconstituted, store at 2–8°C and use within 30 days. Keep away from direct sunlight.
